512 related articles for article (PubMed ID: 33342806)
1. Sildenafil enhances cisplatin-induced apoptosis in human breast adenocarcinoma cells.
Hassanvand F; Mohammadi T; Ayoubzadeh N; Tavakoli A; Hassanzadeh N; Sanikhani NS; Azimi AI; Mirzaei HR; Khodamoradi M; Goudarzi KA; Pourghadamyari H; Zaimy MA
J Cancer Res Ther; 2020; 16(6):1412-1418. PubMed ID: 33342806
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
El-Naa MM; Othman M; Younes S
Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Synergistic Effect of Sildenafil and Green Tea Polyphenols on Breast Cancer Stem Cell-like Cells and their Parental Cells: A Potential Novel Therapeutic Approach.
Sharif MS; Mohseni HS; Khanavi M; Ghadami S; Jafarzadeh E; Tavajohi S; Aliebrahimi S; Ostad SN
Anticancer Agents Med Chem; 2024 Feb; 24(4):304-315. PubMed ID: 37957912
[TBL] [Abstract][Full Text] [Related]
4. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells.
Di X; Gennings C; Bear HD; Graham LJ; Sheth CM; White KL; Gewirtz DA
Breast Cancer Res Treat; 2010 Nov; 124(2):349-60. PubMed ID: 20155316
[TBL] [Abstract][Full Text] [Related]
5. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo.
Nidhyanandan S; Boreddy TS; Chandrasekhar KB; Reddy ND; Kulkarni NM; Narayanan S
Eur J Pharmacol; 2015 Oct; 764():508-519. PubMed ID: 26209365
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism.
Rawat SG; Tiwari RK; Jaiswara PK; Gupta VK; Sonker P; Vishvakarma NK; Kumar S; Pathak C; Gautam V; Kumar A
Apoptosis; 2022 Aug; 27(7-8):606-618. PubMed ID: 35725975
[TBL] [Abstract][Full Text] [Related]
8. Blockade of phosphodiesterase 5 by sildenafil reduces tumor growth and potentiates tumor-killing ability of cisplatin in vivo against T cell lymphoma: Implication of modulated apoptosis, reactive oxygen species homeostasis, glucose metabolism, and pH regulation.
Rawat SG; Tiwari RK; Kumar A
Environ Toxicol; 2024 Apr; 39(4):1909-1922. PubMed ID: 38059649
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
10. Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer.
Domvri K; Zarogoulidis K; Zogas N; Zarogoulidis P; Petanidis S; Porpodis K; Kioseoglou E; Hohenforst-Schmidt W
J Cancer; 2017; 8(18):3648-3656. PubMed ID: 29151951
[No Abstract] [Full Text] [Related]
11. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma.
Urla C; Stagno MJ; Fuchs J; Warmann SW; Schmid E
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2513-2522. PubMed ID: 35764701
[TBL] [Abstract][Full Text] [Related]
13. The Rationale for Repurposing Sildenafil for Lung Cancer Treatment.
Keats T; Rosengren RJ; Ashton JC
Anticancer Agents Med Chem; 2018; 18(3):367-374. PubMed ID: 29110626
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β.
Bellat V; Verchère A; Ashe SA; Law B
BMC Cancer; 2020 Jul; 20(1):661. PubMed ID: 32678032
[TBL] [Abstract][Full Text] [Related]
15. Increased breast cancer cell sensitivity to cisplatin using a novel small molecule inhibitor.
Hatzidaki E; Daikopoulou V; Apostolou P; Ntanovasilis DA; Papasotiriou I
J Cancer Res Ther; 2020; 16(6):1393-1401. PubMed ID: 33342803
[TBL] [Abstract][Full Text] [Related]
16. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
17. Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells.
Czarnomysy R; Surażyński A; Popławska B; Rysiak E; Pawłowska N; Czajkowska A; Bielawski K; Bielawska A
Mol Cell Biochem; 2017 Mar; 427(1-2):13-22. PubMed ID: 27995416
[TBL] [Abstract][Full Text] [Related]
18. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
19. Repurposing of sildenafil as antitumour; induction of cyclic guanosine monophosphate/protein kinase G pathway, caspase-dependent apoptosis and pivotal reduction of Nuclear factor kappa light chain enhancer of activated B cells in lung cancer.
AboYoussef AM; Khalaf MM; Malak MN; Hamzawy MA
J Pharm Pharmacol; 2021 Jul; 73(8):1080-1091. PubMed ID: 33856030
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.
Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
